Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Fibrolamellar hepatocellular carcinoma × Mesna × 1 year × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Leukemia, Myeloid, Acute 12 Myelodysplastic Syndromes 10 Hematologic Neoplasms 8 Lymphoma 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Lymphoma, Non-Hodgkin 5 Leukemia 5 Leukemia, Biphenotypic, Acute 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms 3 Multiple Myeloma 3 Melanoma 3 Leukemia, B-Cell 3 Hodgkin Disease 3 Hematologic Diseases 3 Sarcoma 2 Preleukemia 2 Precancerous Conditions 2 Osteosarcoma 2 Neuroblastoma 2 Neoplasms, Germ Cell and Embryonal 2 Neoplasms by Histologic Type 2 Lymphoproliferative Disorders 2 Lymphatic Diseases 2 Leukemia, Myelomonocytic, Juvenile 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid 2 Leukemia, Lymphoid 2 Leukemia, Lymphocytic, Chronic, B-Cell 2

Interventions

Nivolumab 3 poly ICLC 2 Specimen Handling 2 Sorafenib 2 Irinotecan 2 Ipilimumab 2 sapanisertib 1 pembrolizumab 1 durvalumab 1 dostarlimab 1 dehydroftorafur 1 atezolizumab 1 aflibercept 1 Watchful Waiting 1 Vincristine 1 Surveys and Questionnaires 1 Platinum 1 Oxaliplatin 1 Observation 1 Gemcitabine 1 Fluorouracil 1 Etoposide 1 Doxorubicin 1 DT2216 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡